Yuanshuai Zhou

538 total citations
31 papers, 396 citations indexed

About

Yuanshuai Zhou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yuanshuai Zhou has authored 31 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Yuanshuai Zhou's work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yuanshuai Zhou is often cited by papers focused on RNA modifications and cancer (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yuanshuai Zhou collaborates with scholars based in China, United States and Pakistan. Yuanshuai Zhou's co-authors include Yan Xu, Fujun Qiu, Yongjing Liu, Minxuan Sun, Yong Huang, Junjie Zhang, Lifeng Jiang, Zhicheng Yang, Guangli Suo and Dong Li and has published in prestigious journals such as Nature Immunology, PLoS ONE and Oncogene.

In The Last Decade

Yuanshuai Zhou

30 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanshuai Zhou China 12 256 179 42 34 32 31 396
Zenong Yuan China 10 171 0.7× 69 0.4× 52 1.2× 34 1.0× 35 1.1× 21 317
Feilan Chen China 10 211 0.8× 114 0.6× 50 1.2× 58 1.7× 53 1.7× 25 410
Xuan Kan China 14 349 1.4× 257 1.4× 35 0.8× 78 2.3× 39 1.2× 35 493
I‐Shan Hsieh Taiwan 10 386 1.5× 265 1.5× 42 1.0× 94 2.8× 60 1.9× 12 545
Leilei Chen China 13 210 0.8× 136 0.8× 14 0.3× 74 2.2× 27 0.8× 21 422
Romain Salza France 7 200 0.8× 91 0.5× 17 0.4× 57 1.7× 24 0.8× 8 365
Chenchen Ji China 10 155 0.6× 97 0.5× 29 0.7× 80 2.4× 23 0.7× 25 314
Zewei He China 7 383 1.5× 342 1.9× 29 0.7× 60 1.8× 24 0.8× 7 549
Hui Qian China 12 330 1.3× 231 1.3× 12 0.3× 47 1.4× 39 1.2× 17 432

Countries citing papers authored by Yuanshuai Zhou

Since Specialization
Citations

This map shows the geographic impact of Yuanshuai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanshuai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanshuai Zhou more than expected).

Fields of papers citing papers by Yuanshuai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanshuai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanshuai Zhou. The network helps show where Yuanshuai Zhou may publish in the future.

Co-authorship network of co-authors of Yuanshuai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanshuai Zhou. A scholar is included among the top collaborators of Yuanshuai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanshuai Zhou. Yuanshuai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yue, Yang, Yu Zhao, Minxuan Sun, et al.. (2025). GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches. Biomedicines. 13(2). 382–382.
2.
Hu, James C., Jie Wu, Minxuan Sun, et al.. (2025). Multi-transcriptomics reveals niche-specific expression programs and endothelial cells in glioblastoma. Journal of Translational Medicine. 23(1). 444–444. 2 indexed citations
3.
Zhou, Yuanshuai, et al.. (2024). LPS exposure alleviates multiple tissues damage by facilitating macrophage efferocytosis. International Immunopharmacology. 135. 112283–112283. 2 indexed citations
4.
Ouyang, Nan, et al.. (2023). NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis. Technology in Cancer Research & Treatment. 22. 2223903029–2223903029. 8 indexed citations
5.
Dong, Caihua, Jiao Yang, Ruobing Zhang, et al.. (2023). Cudraflavone B induces human glioblastoma cells apoptosis via ER stress-induced autophagy. BMC Neuroscience. 24(1). 10–10. 6 indexed citations
6.
Wu, Tianhui, Min Xiang, Yujiao Li, et al.. (2023). Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology. Frontiers in Bioscience-Landmark. 28(12). 341–341. 1 indexed citations
7.
Song, Xueyan, Fan Yang, Jun Wang, et al.. (2022). Combined effects of vitamin C and cold atmospheric plasma-conditioned media against glioblastoma via hydrogen peroxide. Free Radical Biology and Medicine. 194. 1–11. 14 indexed citations
8.
Zhang, Tao, Hong Zhang, Cong Liu, et al.. (2022). One-Step Generation and Purification of Cell-Encapsulated Hydrogel Microsphere With an Easily Assembled Microfluidic Device. Frontiers in Bioengineering and Biotechnology. 9. 816089–816089. 16 indexed citations
9.
Lu, Mengyang, et al.. (2022). The molecular mechanisms of ferroptosis and its role in glioma progression and treatment. Frontiers in Oncology. 12. 917537–917537. 10 indexed citations
10.
Zhou, Yuanshuai, Haijun Sun, Rui Liang, et al.. (2021). FEN1 Status and Its Correlation with Clinicopathologic Characteristic inColorectal Cancer. Combinatorial Chemistry & High Throughput Screening. 25(6). 1040–1046. 2 indexed citations
11.
Yu, Yanzhen, Xingzhi Liu, Zhe Zhao, et al.. (2021). The Extracellular Matrix Enriched With Exosomes for the Treatment on Pulmonary Fibrosis in Mice. Frontiers in Pharmacology. 12. 747223–747223. 13 indexed citations
13.
Dong, Caihua, Xinying Li, Jiao Yang, et al.. (2021). PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway. Cell Death and Disease. 12(9). 827–827. 31 indexed citations
15.
Zhou, Yuanshuai, Yanzhen Yu, Junjun Cao, et al.. (2019). Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer's disease. Molecular Omics. 15(6). 459–469. 23 indexed citations
16.
Zhou, Yuanshuai, Fan Zhang, Hai Zhang, et al.. (2018). Nuclear respiratory factor 1 promotes spheroid survival and mesenchymal transition in mammary epithelial cells. Oncogene. 37(47). 6152–6165. 21 indexed citations
17.
Li, Kening, Yong‐Jin Liu, Yuanshuai Zhou, et al.. (2015). An integrated approach to reveal miRNAs’ impacts on the functional consequence of copy number alterations in cancer. Scientific Reports. 5(1). 11567–11567. 7 indexed citations
18.
Zhao, Ning, Yongjing Liu, Zhiqiang Chang, et al.. (2015). Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions. PLoS ONE. 10(9). e0139165–e0139165. 4 indexed citations
19.
Liu, Yongjing, Rui Zhang, Fujun Qiu, et al.. (2014). Construction of a lncRNA–PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer. Molecular BioSystems. 11(2). 384–393. 29 indexed citations
20.
Qiu, Fujun, Yan Xu, Kening Li, et al.. (2012). CNVD: Text mining-based copy number variation in disease database. Human Mutation. 33(11). E2375–E2381. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026